​

Crinetics Pharmaceuticals (CRNX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Crinetics Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$5.42M

Latest Revenue (Q)

$143.00K

Main Segment (Y)

Product

Crinetics Pharmaceuticals Revenue by Period

Crinetics Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$5.42M421.66%
2024-12-31$1.04M-74.11%
2023-12-31$4.01M-15.28%
2022-12-31$4.74M339.42%
2021-12-31$1.08M1418.31%
2020-12-31$71.00K-94.05%
2019-12-31$1.19M-50.86%
2018-12-31$2.43M18.73%
2017-12-31$2.04M247.20%
2016-12-31$589.00K-

Crinetics Pharmaceuticals generated $5.42M in revenue during NA 2025, up 421.66% compared to the previous quarter, and up 7633.80% compared to the same period a year ago.

Crinetics Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$143.00K-86.13%
2025-06-30$1.03M185.60%
2025-03-31$361.00K100.00%
2024-12-31-100.00%
2024-09-30--100.00%
2024-06-30$399.00K-37.66%
2024-03-31$640.00K100.00%
2023-12-31--100.00%
2023-09-30$346.00K-64.98%
2023-06-30$988.00K-63.12%
2023-03-31$2.68M277.86%
2022-12-31$709.00K54.80%
2022-09-30$458.00K4.33%
2022-06-30$439.00K-85.98%
2022-03-31$3.13M190.45%
2021-12-31$1.08M100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--100.00%
2019-09-30$505.00K100.00%
2019-06-30--100.00%
2019-03-31$367.00K-53.01%
2018-12-31$781.00K42.52%
2018-09-30$548.00K-16.59%
2018-06-30$657.00K48.64%
2018-03-31$442.00K-16.29%
2017-12-31$528.00K-17.50%
2017-09-30$640.00K-23.08%
2017-06-30$832.00K1748.89%
2017-03-31$45.00K-

Crinetics Pharmaceuticals generated $143.00K in revenue during Q3 2025, up -86.13% compared to the previous quarter, and up 35.84% compared to the same period a year ago.

Crinetics Pharmaceuticals Revenue Breakdown

Crinetics Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
License and Service$2.28M
Product$5.42M

Crinetics Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (70.43%), and License and Service (29.57%).

Quarterly Revenue by Product

Product/ServiceSep 25
License$14.00M

Crinetics Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: License (100.00%).

Crinetics Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACADACADIA Pharmaceuticals$957.80M$278.63M
SLNOSoleno Therapeutics$190.41M$66.02M
KYMRKymera Therapeutics$39.20M$2.76M
NAMSNewAmsterdam Pharma$22.50M$19.14M
XENEXenon Pharmaceuticals$7.50M-
CRNXCrinetics Pharmaceuticals$5.42M$143.00K
AKROAkero Therapeutics--
VKTXViking Therapeutics--
IMVTImmunovant--
DYNDyne Therapeutics--
PRAXPraxis Precision Medicines--

CRNX Revenue FAQ

What is Crinetics Pharmaceuticals’s yearly revenue?

Crinetics Pharmaceuticals's yearly revenue for 2025 was $5.42M, representing an increase of 421.66% compared to 2024. The company's yearly revenue for 2024 was $1.04M, representing a decrease of -74.11% compared to 2023. CRNX's yearly revenue for 2023 was $4.01M, representing a decrease of -15.28% compared to 2022.

What is Crinetics Pharmaceuticals’s quarterly revenue?

Crinetics Pharmaceuticals's quarterly revenue for Q3 2025 was $143K, a -86.13% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.03M, a 185.60% increase from the previous quarter (Q1 2025), and a 158.40% increase year-over-year (Q2 2024). CRNX's quarterly revenue for Q1 2025 was $361K, a 100.00% increase from the previous quarter (Q4 2024), and a -43.59% decrease year-over-year (Q1 2024).

What is Crinetics Pharmaceuticals’s revenue growth rate?

Crinetics Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 35.06%, and for the last 5 years (2021-2025) was 402.78%.

What are Crinetics Pharmaceuticals’s revenue streams?

Crinetics Pharmaceuticals's revenue streams in c 25 are License and Service, and Product. License and Service generated $2.28M in revenue, accounting 29.57% of the company's total revenue Product generated $5.42M in revenue, accounting 70.43% of the company's total revenue

What is Crinetics Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Crinetics Pharmaceuticals was Product. This segment made a revenue of $5.42M, representing 70.43% of the company's total revenue.